News

Article

Novartis Expands Biologics Production in France

Jacobs Engineering will provide engineering and construction services to expand the Novartis site in Huningue, France.

Jacobs Engineering Group was awarded a contract to expand the Novartis Pharma S.A.S. Biotechnology Center in Huningue, France, the company announced on Aug. 11, 2016. Under the terms of the agreement, Jacobs is providing engineering, procurement, and construction management services to increase the site’s production capacity by 70% and create a second line of purification that allows for multiple drugs to be manufactured simultaneously.

Already one of the world’s largest production facilities for monoclonal antibodies from mammalian cells, the expansion project adds cell culture bioreactors to the site. The $100 million expansion project is scheduled to be completed in four years. Jacobs’ services are being led from its operations in Milan, Italy.

Source: Jacobs Engineering

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content